|
|
|
|
- Last November, 75 experts presented current research and deliberated issues related to focused ultrasound and gene and cell therapy for neurodegenerative disorders.
- The summary white paper, which includes four immediate action items, is now available.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
- On Wednesday, the Foundation hosted a webinar on focused ultrasound for conditions that disproportionately affect women.
- Four experts discussed the technology’s potential for Alzheimer’s disease, chronic pain, depression and anxiety, and some cancers.
|
|
|
|
|
|
|
|
|
|
|
|
- A proposed $12 billion would fund research to prevent, diagnose, and treat rheumatoid arthritis, menopause, Alzheimer’s disease, endometriosis, and more.
- The Foundation is advocating for increased funding for women’s health focused ultrasound research.
|
|
|
|
|
|
|
|
|
|
|
|
- The device, called DIADEM, measures and compensates for the attenuation of ultrasound caused by the human head and hair.
- Results from clinical trials support its effective and safe deployment in patients with treatment-resistant depression and chronic pain.
|
|
|
|
|
|
|
|
|
|
|
|
- SPIRE is a neuromodulation company developing therapeutic ultrasound for depression and chronic pain.
- The company is now conducting clinical trials with its innovative neuromodulation device called DIADEM.
|
|
|
|
|
|
|
|
|
|
|
|
- RebrAIn pairs artificial intelligence with health data to simplify and standardize targeting for neurological procedures.
- Learn how the technology works for surgical interventions and how the company plans to apply it to focused ultrasound treatments.
|
|
|
|
|
|
|
|
|
|
|
|
- The Foundation is proud to be a part of ARPANET-H, a nationwide health innovation network that connects people, innovators, and institutions.
- Our hub aims to diversify clinical trials and instill patient-centric approaches to improve health outcomes for Americans.
|
|
|
|
|
|
|
|
|
|
|
|
- The Foundation’s Chairman recently shared the state of the field for focused ultrasound on NPR’s BioTech Nation.
- He also highlighted exciting developments on the horizon, including treating addiction and neurodegenerative conditions.
|
|
|
|
|
|
|
|
|
|
|
|
- In this neuropathic facial pain clinical trial, the intervention failed to benefit study participants.
- The small cohort size may have limited the results.
|
|
|
|
|
|
|
|
|
|
|
|
- The 185th Meeting of the Acoustical Society of America (ASA) took place in Sydney, Australia, December 4–8.
- The program included 29 abstracts that may be of interest to the field.
|
|
|
|
|
|
|
|
|
|
“The women are ready. The patients are ready. They are ready to embrace this modality, and they know the power that it can have.”
‒ Elisa Konofagou, PhD, during the women’s health webinar |
|
|
|
|
|
|